BELIEFS AND PRACTICES OF EMERGENCY-MEDICINE FACULTY AND RESIDENTS REGARDING PROFESSIONAL INTERACTIONS WITH THE BIOMEDICAL INDUSTRY

被引:20
作者
KEIM, SM
SANDERS, AB
WITZKE, DB
DYNE, P
FULGINITI, JW
机构
[1] Section of Emergency Medicine, University of Arizona College of Medicine, Tucson
关键词
biochemical industry;
D O I
10.1016/S0196-0644(05)81262-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To examine emergency medicine resident training and understanding of general bioethics and resident and faculty attitudes and behavior regarding professional interactions with the biomedical industry. Design: Two companion questionnaire surveys. Setting: Annual resident in-service examination and written director survey with telephone follow-up. Participants: Emergency medicine residents and program directors. Interventions: Chi2 analysis was used for questions involving relationships among variables with dichotomous or categorical response. An analysis of variance or Pearson Product Moment Correlation was calculated for questions with continuous variables. Measurements and main results: The surveys were completed by 1,385 of 1,836 (75%) residents and 80 of 81 (99%) residency directors. On average, residents receive eight hours of bioethical instruction per year but believe that they need 12 hours per year. Seventy-five percent of residents believe that company representatives sometimes cross ethical boundaries. The amount of resident understanding of bioethical concepts correlated with the number of hours of bioethics training they received. A sensitivity to bioethical conflicts index was correlated with the residents' behavior. Conclusion: There is wide variation in beliefs and practices regarding the interaction between emergency medicine residents and directors and the biomedical industry. Our results suggest that residents need training regarding conflicts of interest, accepted standards of practice, and dealing with potential conflicts with the biomedical industry.
引用
收藏
页码:1576 / 1581
页数:6
相关论文
共 36 条
[1]  
Royal College of Physicians, The relationship between physicians and the pharmaceutical industry, J R Coll Phys Lond, 20, pp. 235-242, (1986)
[2]  
American College of Physicians, Physicians and the pharmaceutical industry, Annals of Internal Medicine, 112, pp. 624-626, (1990)
[3]  
American Medical Association, Gifts to physicians from industry, JAMA: The Journal of the American Medical Association, 265, (1991)
[4]  
Accreditation Council for Continuing Medical Education, Guidelines for commercial support of continuing medical education, (1991)
[5]  
Kessler, Pines, The federal regulation of prescription drug advertising and promotion, JAMA, 264, pp. 2409-2415, (1990)
[6]  
Chren, Landefeld, Murray, Doctors drug companies and gifts, JAMA: The Journal of the American Medical Association, 262, pp. 2448-2451, (1989)
[7]  
Avorn, Chen, Hartley, Scientific versus commercial sources of influence on the prescribing behavior of physicians, Am J Med, 73, pp. 4-8, (1982)
[8]  
McKinney, Schiedermayer, Lurie, Et al., Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives, JAMA, 264, pp. 1693-1697, (1990)
[9]  
Kessler, Drug promotion and scientific exchange, N Engl J Med, 325, pp. 201-203, (1991)
[10]  
Shimm, Spece, Industry reimbursement for entering patients into clinical trials: Legal and ethical issues, Ann Intern Med, 115, pp. 148-151, (1991)